Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10045/110274
Título: | Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization |
---|---|
Autor/es: | Sánchez-Heras, Ana Beatriz | Castillejo, Adela | García-Díaz, Juan D. | Robledo, Mercedes | Teulé, Alexandre | Sánchez, Rosario | Zúñiga, Ángel | Lastra, Enrique | Durán, Mercedes | Llort, Gemma | Yagüe, Carmen | Ramon y Cajal, Teresa | López San Martin, Consol | López-Fernández, Adriá | Balmaña, Judith | Robles, Luis | Mesa-Latorre, José M. | Chirivella, Isabel | Fonfria, María | Perea Ibañez, Raquel | Castillejo, María Isabel | Escandell, Inés | Gomez, Luis | Berbel, Pere | Soto, José Luis |
Grupo/s de investigación o GITE: | Biotecnología | Genética Humana y de Mamíferos (GHM) |
Centro, Departamento o Servicio: | Universidad de Alicante. Departamento de Biotecnología | Universidad de Alicante. Departamento de Fisiología, Genética y Microbiología |
Palabras clave: | Leiomyomas | Hereditary leiomyomatosis | FH gene | Missense pathogenic variants | Renal cell cancer |
Área/s de conocimiento: | Biología Celular | Genética |
Fecha de publicación: | 5-nov-2020 |
Editor: | MDPI |
Cita bibliográfica: | Sánchez-Heras AB, Castillejo A, García-Díaz JD, Robledo M, Teulé A, Sánchez R, Zúñiga Á, Lastra E, Durán M, Llort G, Yagüe C, Ramon y Cajal T, López San Martin C, López-Fernández A, Balmaña J, Robles L, Mesa-Latorre JM, Chirivella I, Fonfria M, Perea Ibañez R, Castillejo MI, Escandell I, Gomez L, Berbel P, Soto JL. Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization. Cancers. 2020; 12(11):3277. https://doi.org/10.3390/cancers12113277 |
Resumen: | Hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) is a very rare hereditary disorder characterized by cutaneous leiomyomas (CLMs), uterine leiomyomas (ULMs), renal cysts (RCys) and renal cell cancers (RCCs). We aimed to describe the genetics, clinical features and potential genotype-phenotype associations in the largest cohort of fumarate hydratase enzyme mutation carriers known from Spain using a multicentre, retrospective study of individuals with a genetic or clinical diagnosis of HLRCC. We collected clinical information from medical records, analysed genetic variants and looked for genotype-phenotype associations. Analyses were performed using R 3.6.0. software. We included 197 individuals: 74 index cases and 123 relatives. CLMs were diagnosed in 65% of patients, ULMs in 90% of women, RCys in 37% and RCC in 10.9%. Twenty-seven different pathogenic variants were detected, 12 (44%) of them not reported previously. Patients with missense pathogenic variants showed higher frequencies of CLMs, ULMs and RCys, than those with loss-of-function variants (p = 0.0380, p = 0.0015 and p = 0.024, respectively). This is the first report of patients with HLRCC from Spain. The frequency of RCCs was lower than those reported in the previously published series. Individuals with missense pathogenic variants had higher frequencies of CLMs, ULMs and RCys. |
URI: | http://hdl.handle.net/10045/110274 |
ISSN: | 2072-6694 |
DOI: | 10.3390/cancers12113277 |
Idioma: | eng |
Tipo: | info:eu-repo/semantics/article |
Derechos: | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
Revisión científica: | si |
Versión del editor: | https://doi.org/10.3390/cancers12113277 |
Aparece en las colecciones: | INV - GIDBT - Artículos de Revistas INV - GHM - Artículos de Revistas |
Archivos en este ítem:
Archivo | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Sanchez-Heras_etal_2020_Cancers.pdf | 1,31 MB | Adobe PDF | Abrir Vista previa | |
Este ítem está licenciado bajo Licencia Creative Commons